Cleared Traditional

K990693 - FLEXNEEDLE PLUS

K990693 is an FDA 510(k) clearance for FLEXNEEDLE PLUS, manufactured by Act Medical, Inc.. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 72-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1999
Decision
72d
Days
Class 2
Risk

K990693 is an FDA 510(k) clearance for the FLEXNEEDLE PLUS. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Act Medical, Inc. (Newton, US). The FDA issued a Cleared decision on May 14, 1999 after a review of 72 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Act Medical, Inc. devices

FDA 510(k) Submission Details - K990693

510(k) Number K990693 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 03, 1999
Decision Date May 14, 1999
Days to Decision 72 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
57d faster than avg
Panel avg: 129d · This submission: 72d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 514
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K990693.
CADD ADMINISTRATION SET
K991599 · Sims Deltec, Inc. · Jun 1999
CADD-TPN ADMINISTRATION SET, MODEL 21-7071
K991255 · Sims Deltec, Inc. · Jun 1999
CADD-PRIZM HIGH VOLUME ADMINISTRATION SET WITH 1.2 U FILTER AND ADD-ON ANTI-SIPHON VALVE, CADD ADMINISTRATION SET WITH 1
K991301 · Sims Deltec, Inc. · Jun 1999
KVO CHECK VALVE ACCESSORY, MODEL EV-0001
K984441 · I-Flow Corp. · Feb 1999
BURETROL SOLUTION SETS
K984381 · Baxter Healthcare Corp · Feb 1999
CADD ADMINISTRATION SET, CADD 250ML FLEXIBLE MEDICATION RESERVOIR, MODIFIED SECURIT SHELL, SECURITY SHELL ADAPTER
K990083 · Sims Deltec, Inc. · Feb 1999